A quality improvement project reducing adverse events and improving adherence to guidelines surrounding VRIII usage.

2 17 We showed a trend towards improvement in the correct continuation of long-acting insulin post-intervention, however this improvement then reversed back to the baseline level at the 1-year follow-up.

also in 53,322 other papers

The number of VRIII episodes where no fluid was used as substrate was also reduced from 7.4% at baseline to 3.8% peri-intervention (p=0.36) and 3.9% post-intervention (p=0.22), although the difference did not reach statistical significance.

also in 111,027 other papers